Citrus Bioflavonoids Market Size & Share 2023 to 2032
Market Size by Source (Orange, Tangarines, Mandarins, Limes & Lemons, Grapefruit), by Product (Hesperitin, Eriocitrin, Apigenin, Diosmin, Naringin, Narirutin), by Type (Conventional, Organic), Application & Forecast.
Report ID: GMI4827
|
Published Date: June 2023
|
Report Format: PDF
Download Free PDF
Authors:
Kiran Pulidindi, Kunal Ahuja
Citrus Bioflavonoids Market Size
Citrus Bioflavonoids Market size surpassed USD 942 million in 2022 and is projected to depict 8% CAGR from 2023 to 2032. Positive outlook in the pharmaceuticals & dietary supplements, food & beverages along with animal feed and Cosmetics & Personal care industry will fuel the market growth. Citrus bioflavonoids are extracted from fruits rich in vitamin C, and work by neutralizing free radicals. These are compounds majorly found in citrus fruits including grapefruit, tangerines and oranges.
Citrus Bioflavonoids Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Citrus bioflavonoids provide several health benefits, and they are the key driver of industry growth. The increasing health awareness among consumers has propelled the demand for citrus bioflavonoids in packaged food and beverages. It can be utilized as a flavoring agent as well as a preservative in the food sector. Citrus bioflavonoids are commonly found in alcoholic and quick beverage products. Citrus bioflavonoids are extensively utilized as a functional ingredient to boost nutritional value in a variety of meals and beverages.
The rising citrus bioflavonoids market demand is also due to the rising prevalence of chronic conditions such as diabetes, high blood pressure, and high sugar levels. Citrus bioflavonoids, which have antibacterial, antiviral, antioxidant, blood pressure-lowering, and anti-inflammatory activities, are used to prevent these diseases. Citrus bioflavonoids' anti-inflammatory and antioxidant characteristics aid in the treatment of cancer, asthma, and cardiovascular diseases.
COVID-19 Impact
Citrus bioflavonoids, which are natural compounds found in citrus fruits, are known for their potential health benefits including immune system support. During the pandemic, there has been a growing interest in products that enhance immune functions. The COVID-19 pandemic caused disruptions in global supply chains due to restrictions on transportation and trade. Citrus bioflavonoids are often derived from citrus fruits and any disruptions in the supply chain can affect the availability of raw materials.
The pandemic resulted in changes in consumer behavior and spending patterns. With economic uncertainties and changes in priorities, consumers may have reduced their spending on non-essential items including dietary supplements or functional ingredients such as citrus bioflavonoids. The pandemic also impacted research & development activities in various industries. Companies and research institutions may have redirected their resources & efforts toward COVID-19-related research, potentially affecting the pace of innovation and new product developments in the citrus bioflavonoids market.
Citrus bioflavonoids Industry Trends
In the marketing year 2021/2022, Brazil emerged as the top global producer of oranges, yielding approximately 16.9 million metric tons. During the same period, the total global production of fresh oranges reached around 49.01 million metric tons., as favorable weather leads to a higher crop in Brazil (up 7%), and Mexico (up nearly 60 percent). The majority of the increased output is likely to go into fruit processing, with consumption and exports remaining unchanged. Brazil's output is expected to increase by 7%. Increased consumer spending on dietary supplements has stemmed from constant rises in healthcare expenses in both developed and developing countries. Furthermore, the number of fitness enthusiasts and health-conscious individuals is growing. These elements are expected to boost this target market revenues.
Citrus Bioflavonoids Market Analysis
The conventional segment will hold major citrus bioflavonoids market share during the forecast period. Conventional citrus bioflavonoids are found naturally in the fruits which are rich in vitamin C. The conventional type is considered to be pure and free from any harmful chemicals. Thus, the product demand is high, especially in food and beverages application.
The orange sub-segment is anticipated to capture highest industry share. Oranges are the best conventional source for citrus bioflavonoids. Also, oranges are used in the manufacturing of various food and beverages products owing to its flavors. The leading orange producing countries are Brazil, China, EU and US. Brazil topped the orange production by producing 16.91 million metric tons of oranges in 2021-2022.
The growing demand for clean label products by the fitness enthusiast consumers is driving the citrus bioflavonoids market. Also, the growing trend of eliminating the use of phosphates, titanium dioxide, carrageenan, etc., will propel the demand for citrus bioflavonoids in packaged food and beverages. In pharmaceutical industry, Citrus Bioflavonoids used as a flavoring agent and provide bitter taste notes to the final formulation. It can also be used as natural preservatives thanks to its antimicrobial, antifungal and antioxidant properties. Thanks to its different benefits in vascular health, immune system, cholesterol control, etc.
The pharmaceutical & dietary supplements captured around 68% global share and will grow with decent pace. In Animal feed, Citrus Bioflavonoids can provide notes of bitter taste to different formulations directed to animal feed and welfare sectors. They are used as natural preservatives in different products thanks to its antimicrobial, antifungal and antioxidant properties. Owing to their different nutraceutical and health benefits, they could also be added in different formulations and products with the aim of preventing some common diseases.
Eriocitrin segment is expected to grow significantly, followed by the Naringin section. Eriocitrin is a lemon flavonoid extracted from citrus fruits like lemons that research suggests can play a positive role in supporting healthy blood sugar levels, cardiovascular health, and more. Eriocitrin is mostly employed in the production of dietary supplements due to its ability to reduce lipid levels in liver cells. Eriocitrin can also be utilized to control blood glucose levels, boosting the citrus bioflavonoids market progression.
North America citrus bioflavonoids industry is estimated to account for major attributed to the high production of blueberries in US and Canada and rapidly growing food and beverage industries in the region. In year 2021-2022, US produced 3.47 million metric ton of oranges. Europe is estimated to witness significant gains during 2023-2032. The local population of the region is inclined towards nutritious food products due to the growing per capita income. Further, the rising geriatric population is leading to a strong growth of the product in pharmaceutical applications. The high use of herbal extracts in countries such as Germany, U.K., France and other European countries is expected to support the regional market statistics.
Citrus Bioflavonoids Market Share
Some of the major market players operating in the citrus bioflavonoids market are:
These players focus on strategic partnerships, new product launch & commercialization for industry expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum business revenue.
Citrus Bioflavonoids Industry News:
This citrus bioflavonoids market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million & Tons from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
Market, By Source
Market, By Application
Market, By Type
The above information is provided for the following regions and countries:
Market, By Region
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →